As NETs directly promote atherosclerosis, the use of specific PADI4-inhibitors, in order to suppress the PADI4-dependent NET formation, might have therapeutic benefits in atherosclerosis [43] and cardiovascular complications [44]. This evidence concerns the gene PADI4 and atherosclerosis.